ArticleEndocrinology and metabolism (Seoul, Korea)2021

New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors.

Chan-Hee JungPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.